Robotic surgery is now preferred by majority of the gynecologist for the surgical treatment of patients with gynecologic malignancies including endometrial, prolapsed or falling of pelvic organs, ovarian cysts & masses, uterine fibroids, cervical, and ovarian cancer with partial metastatic disease. Gynecologic surgery removes the cancerous cells with a high level of care, leading to a better degree of surgical accuracy with a lower possibility of risk and complications compared to conventional procedures. Some of the other procedures include pelvic & aortic lymphadenectomy, pelvic recurrences, radical trachelectomy, radical hysterectomy, resection of diaphragm & liver metastases and isolated recurrences of ovarian cancer.
The major advantages associated are smaller incisions, faster recovery, fewer post-operative complications, decreased risk of infection, early return to normal activities, less pain and shorter hospital stay.
According to study, “Global Gynecological Surgery Robots Market 2016-2025: Market Size, Share, Forecast and Strategy” some of the major companies that are currently working in the global gynecological surgery robots market are AVRA Surgical Robotics, Inc., Medrobotics Corporation, CAE Healthcare, NovaTract Surgical, Inc., Intuitive Surgical, Omni Guide, Inc., Medtronic Inc., Titan Medical, Simbionix USA Corp., TransEnterix, Inc.
Based on components, global gynecological surgery robotic market is segmented into a console, camera, robotic cart and wristed instruments. In console, the surgeon makes an analysis or view from the screen, manages the instruments & camera by finger graspers & foot pedals. Camera allows for a three dimensional or 3D image of the pelvis with image synchronizers & illuminators. Robotic cart includes three or four interactive arms that hold apparatuses through trocars attached to the patient.
Based on disease type, the market is segmented into endometrial cancer, ovarian cancer and cervical cancer. Based on technology market is segmented into pelvic organ prolapsed repair, hysterectomy, myomectomy (removal of fibroids), endometriosis, adnexal surgery, pediatric gynecology, tubal anastomosis, tubal re-anastomosis, sacrocolpopexy (treatment for pelvic organ prolapsed) & hysteropexy, interval cervical suture placement, robotic assisted laparoscopic (removal of fibroids), and gynecologic oncology. Hysterectomy is further sub-segmented into radical hysterectomy and simple hysterectomy. Radical hysterectomy removes uterosacral ligaments, parametria (bands of connective tissue in the pelvis), and upper vagina. Simple hysterectomy involves removal of the uterus & cervix. Based on end-user, market is segmented into hospitals & clinics, physicians’ offices, ambulatory surgical centers (ASCs) and others.
The International Federation of Gynecology & Obstetrics (FIGO) brings together professional or trained societies of gynecologists from the global locations. It aims to promotes the safety of women and raise standard of practice in gynecology.
The global gynecological surgery robots is driven by increase in preference for minimally invasive surgery (MIS), followed by increase in demand for procedures, increase in number for gynecological disorders, enhance precision and need of eliminating any revisions with high adoption of robotic-assisted techniques. Some of the other factors supporting the adoption of MIS across the world are reduced hospital stay, recovery time, and postoperative pain. In addition, one prime factor lead to the rise in demand includes patient satisfaction that supports the manufacturers to extend more advanced robotic equipment.
It is also expected that the global gynecological surgery robot market to reach at US $2.9 billion, by 2025.
For more information, click on the link below:
Global Gynecological Surgery Robots Market
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91 9015378249
